Drug Companies Have a Sneaky Idea to Get Insurance to Pay for Drugs Like Zepbound

popular weight loss medications, one of the pharma companies behind the new treatments is making an interesting gambit: sponsoring studies into whether they can help treat other conditions.

"It builds this wall of evidence," explained Derek Asay, Lilly's senior vice president of government strategy and federal accounts. "It helps give that reason to believe there’s more than weight loss here." Known as glucagon-like peptide-1 agonists, drugs like Zepbound and Novo Nordisk's Ozempic and Wegovy are becoming known not just for inducing weight loss as they mimic the gut's feeling of fullness, but also for seemingly helping with other conditions ranging from

As more and more of these off-label uses begin cropping up in anecdotal evidence and studies, the companies that have made a killing off of them are hoping to get broader insurance coverage once regulatory agencies approve them for conditions outside of weight loss and diabetes.

I understand and agree that registration on or use of this site constitutes agreement to its User Agreement and Privacy Policy

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

The secret to weight loss that drug companies don't want you to knowSome of these medications don't have to break the bank.
출처: 10News - 🏆 732. / 50 더 많은 것을 읽으십시오 »

Major drug companies cap asthma medication costs at $35 per monthMajor pharmaceutical companies have agreed to cap out-of-pocket costs for some asthma patients, but critics argue it's only part of the solution to high drug prices.
출처: WGAL - 🏆 331. / 59 더 많은 것을 읽으십시오 »

Tobacco companies are no different from drug pushers in peddling sickness and deathhe tobacco companies are no different than illegal drug dealers. As long as they make money, they couldn’t care less who becomes addicted, or how it affects the health and quality of life for those using.
출처: PennLive - 🏆 463. / 53 더 많은 것을 읽으십시오 »

New Pennsylvania bill makes pharmacies report funding from drug companiesLegislation restricting the actions of unscrupulous pharmacy benefit managers, or PBM’s, heads to the governor’s desk this week.
출처: nypost - 🏆 91. / 67 더 많은 것을 읽으십시오 »